ORPHA:2615
Nakajo-Nishimura syndrome
Also known as: Amyotrophy-fat tissue anomaly syndrome · Secondary hypertrophic osteoperiostosis with pernio
Publications
143
Trials
1
Interventional, condition-specific
Researchers
678
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
143 matched papers (104 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialPresent
1 matched on ClinicalTrials.gov
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
143
143 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
143 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
104 in the last 10 years · low confidence
Phrase hits: 143 · MeSH hits: 0
Who's working on it?
678
Distinct author names in 143 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Kanazawa N18 papers · 2026
Department of Dermatology, Wakayama Medical University, Wakayama, Japan. nkanazaw@hyo-med.ac.jp.
Papers in Europe PMC - 02Goldbach-Mansky R13 papers · 2023
Translational Autoinflammatory Disease Studies, National Institute of Allergy and Infectious Diseases (NIAID), and NIAMS, National Institutes of Health (NIH), Bethesda, MD, USA. goldbacr@mail.nih.gov.
Papers in Europe PMC - 03Krüger E9 papers · 2023
Inflammatory Disease Section, National Human Genome Research Institute, NIH, Bethesda, Maryland, USA.
Papers in Europe PMC - 04Furukawa F8 papers · 2020
Wakayama Medical University, Department of Dermatology, Wakayama, Japan
Papers in Europe PMC - 05Saito MK8 papers · 2022
Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
Papers in Europe PMC - 06Ebstein F7 papers · 2023
Institut für Biochemie, Charité-Universitätsmedizin Berlin Campus CVK, Germany.
Papers in Europe PMC - 07Honda-Ozaki F5 papers · 2021
Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan.
Papers in Europe PMC - 08Kunimoto K5 papers · 2021
Department of Dermatology, Wakayama Medical University, Wakayama, Japan.
Papers in Europe PMC - 09de Jesus AA4 papers · 2023
Translational Autoinflammatory Diseases Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, Maryland 20892; email: goldbacr@mail.nih.gov.
Papers in Europe PMC - 10Hadef D4 papers · 2022
Department of Pediatrics, University Hospital Center of Batna, Faculty of Medicine, Batna 2 University
Papers in Europe PMC
Clinical research
Is a treatment being tested?
1
interventional trials for this specific condition
1 interventional trial matched this specific condition name; none in our sample are currently recruiting.
Data as of 27 July 2026
1 interventional trial — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 76.8th percentile).
low confidence · 76.8th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
1 interventional trials matched after quoted-phrase search and title/condition post-filter.
No currently recruiting studies in the matched set. Open the same search on ClinicalTrials.gov.
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Nakajo-Nishimura syndrome" OR "Amyotrophy-fat tissue anomaly syndrome" OR "Secondary hypertrophic osteoperiostosis with pernio"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Nakajo-Nishimura syndrome" OR "Amyotrophy-fat tissue anomaly syndrome" OR "Secondary hypertrophic osteoperiostosis with pernio"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 1 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- "Nakajo-Nishimura syndrome" also appears on ORPHA:324977
- "Secondary hypertrophic osteoperiostosis with pernio" also appears on ORPHA:324977
- No Orphanet definition and no Mondo IDs — likely taxonomy scaffolding; confidence capped at low
Ingested 2026-07-26T20:41:38.818Z